Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders

Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders

US Patent 8987247 · Granted Mar 24, 2015

Estimated economic value: $61,547,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a fac2025
Immunoglobulins and uses thereof2024
Pyridine N-oxide derivatives useful as factor XIa inhibitors2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neu2023
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y recep2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neu2023
Immunoglobulins and uses thereof2022
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors2022
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y recep2021
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neu2021
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y recep2021
Immunoglobulins and uses thereof2020